Patent · US Expired

O-Alkylated oximes and pharmaceutical composition thereof

US4358450A · kind A · utility

7Cited by
7References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 1979
Grant dateNov 9, 1982
Priority date
Expiry dateAug 6, 1999

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/22
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of general formula ##STR1## wherein R.sup.1 represents a member selected from the group consisting of (a) an unsubstituted at most binuclear aryl group having from 6 to 10 carbon atoms, such groups substituted by from 1 to 3 equal or different radicals selected from the group consisting of alkyl, halogenoalkyl, alkoxy, dialkylamino each having up to 4 carbon atoms in the alkyl moiety, halogen phenyl, carboxyl, cyano, nitro and hydroxy groups, PA0 (b) a 5- to 6-membered heteroaromatic ring wherein the heteroatom is selected from nitrogen, oxygen and sulfur atoms and such rings anellated to a benzene nucleus; PA0 R.sup.2 represents a member selected from the group consisting of hydrogen, alkyl having up to 3 carbon atoms, phenyl, cycloalkyl having up to 6 carbon atoms in the ring and cycloalkyl bearing a hydrocarbon bridging radical having up to 2 carbon atoms; PA0 R.sup.3 represents hydrogen, hydroxy or acyloxy; PA0 R.sup.4 and R.sup.5 are the same or different and each represents a member selected from the group consisting of halogen, alkyl, and halogenoalkyl each having up to 3 carbon atoms, and nitro; and PA0 X represents nitrogen or methine PA0 and physiologically acce…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.